ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 305802 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 305802; 2) Community: the network communities that were significantly associated with the response to NSC 305802; 3) Molecule: the relationships between components within communities and NSC 305802; 4) MDR: the compounds that were significantly associated with the NSC 305802.

NSC Compound Enrichment Correlation
NSC 345647 CHAETOCHROMIN 0.00162803849483079 0.31553826
NSC 616348 Irinotecan hydrochloride 0.00162803849483079 0.40603726
NSC 618939 Camptothecin Derivative 0.00162803849483079 0.3914122
NSC 646127 6H-Pyrido[4,3-b]carbazole, 1,2-dihydro-2,5,9,11-tetra- methyl- 0.00162803849483079 -0.067692773
NSC 647117 Null 0.00162803849483079 0.17172024
NSC 667545 Null 0.00162803849483079 0.3311855
NSC 710340 6H,7H-[1]Benzopyrano[4,3-b][1]benzopyran-7-one,3,8,10-tri hydroxy-9,11-bis(3-methyl-2-butenyl)-6-(2-methyl-1-propenyl)- (9CI) 0.00162803849483079 0.25463249
NSC 725774 6-[3-(Bis-hydroxyethylamino)-1-propyl]-5,6-dihydro-2,3-~ dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride 0.00162803849483079 0.49083869
NSC 726373 Null 0.00162803849483079 0.20120685
NSC 735037 Camptothecin Derivative 0.00162803849483079 0.31595561
Total:122  Current:10    [First] [Prev] [Next] [Last]